Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial

Introduction  This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of treatment with rivaroxaban or a vitamin-K antagonist (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchhof, Paulus, Ezekowitz, Michael D., Purmah, Yanish, Schiffer, Sonja, Meng, Isabelle L., Camm, A. John, Hohnloser, Stefan H., Schulz, Anke, Wosnitza, Melanie, Cappato, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978177/
https://www.ncbi.nlm.nih.gov/pubmed/31984306
http://dx.doi.org/10.1055/s-0040-1701206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978177/
https://www.ncbi.nlm.nih.gov/pubmed/31984306
http://dx.doi.org/10.1055/s-0040-1701206

Ejemplares similares